Veterinary Medicines

Fatroximin 100 mg/13,4 g putas ievadīšanai dzemdē govīm un ķēvēm

Authorised
  • Rifaximin
Download as PDF

Product identification

Medicine name:
Fatroximin 100 mg/13,4 g putas ievadīšanai dzemdē govīm un ķēvēm
Active substance:
  • Rifaximin
Target species:
  • Cattle (cow)
  • Horse (mare)
Route of administration:
  • Intrauterine use

Product details

Active substance and strength:
  • Rifaximin
    100.00
    milligram(s)
    /
    1.00
    Vial
Pharmaceutical form:
  • Intrauterine foam
Withdrawal period by route of administration:
  • Intrauterine use
    • Cattle (cow)
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse (mare)
      • Meat and offal
        0
        day
      • Milk
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • PVD
Authorisation number:
  • V/NRP/01/1371
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 27/02/2024
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 27/02/2024
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 27/02/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."